Back

Real-world use of oral semaglutide in adults with type 2 diabetes: the PIONEER REAL Switzerland multicentre, prospective, observational study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic and diabetes Diabetes and the Heart ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Flavio Acquistapace

Medical in Practice Association, Lugano (Switzerland)

3 More presentations in this session

Presentation thumbnail
Serum iron predicts long-term cardiovascular outcomes in diabetic patients with coronary artery disease, independent of iron status
Doctor J. Cheng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Baseline characteristics and clinical outcomes of patients with type 2 diabetes and cardiovascular disease treated with GLP-1 receptor agonists and SGLT2 inhibitors
Doctor R. Hilu (Kfar Saba, IL)
Abstract Slides Video
Presentation thumbnail
Effect of oral semaglutide on remnant-like lipoprotein cholesterol in patients with ischemic heart disease receiving statin therapy
Doctor S. Watanabe (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiometabolic and diabetes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Relationship between baseline LDL cholesterol levels and cardiovascular outcomes in adults with cardiovascular disease and overweight or obesity: an exploratory analysis of the SELECT trial
thumbnail
Congress Presentation
5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment
thumbnail
Congress Presentation
Semaglutide for the secondary prevention of cardiovascular disease in people with overweight or obesity, but without diabetes: a cost-effectiveness analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources